Creso Pharma Limited (COPHF)
USD 0.12
(0.0%)
USD 0.12
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 18.92 Million | 8.68 Million | 6.21 Million | 2.44 Million | 3.62 Million | 578.22 Thousand |
| Cost of Revenue | 16.58 Million | 8.4 Million | 6.61 Million | 6.33 Million | 1.5 Million | 353.56 Thousand |
| Gross Profit | 2.33 Million | 287 Thousand | -400.61 Thousand | -3.88 Million | 2.12 Million | 224.65 Thousand |
| Operating Expenses | 19.01 Million | 19.47 Million | 27.95 Million | 10.48 Million | 12.3 Million | 16.41 Million |
| Selling, General and Administrative Expenses | 6.05 Million | 7.89 Million | 10.18 Million | 4.25 Million | 6.33 Million | 12.07 Million |
| Research and Development Expenses | - | - | - | 344.98 Thousand | 286.02 Thousand | 286.53 Thousand |
| Other Expenses | -1.45 Million | -459 Thousand | 28.44 Thousand | -2.47 Million | -91.01 Thousand | 62.95 Thousand |
| Cost and Expenses | 52.73 Million | 27.88 Million | 34.57 Million | 16.81 Million | 13.8 Million | 16.77 Million |
| Operating Income | -15.19 Million | -19.56 Million | -28.32 Million | -16.83 Million | -10.2 Million | -15.98 Million |
| Interest Expense | 9.69 Million | 692 Thousand | 1.7 Million | 9.26 Million | 2.09 Million | 432.21 Thousand |
| Income Tax Expense | -3000.00 | 2000.00 | 1.73 Million | 6.79 Million | 1.71 Million | 405.52 Thousand |
| Earnings before Tax | -35.52 Million | -32.78 Million | -30.03 Million | -30.77 Million | -15.33 Million | -16.84 Million |
| Net Income | -52.44 Million | -32.78 Million | -30.03 Million | -30.77 Million | -15.05 Million | -16.75 Million |
| Earnings Per Share Basic | -0.38 | -0.02 | -0.03 | -0.08 | -0.10 | -0.15 |
| Earnings Per Share Diluted | -0.38 | -0.02 | -0.03 | -0.08 | -0.10 | -0.15 |
| Weighted Average Shares Outstanding | 139.42 Million | 1.46 Billion | 1.1 Billion | 370.83 Million | 143.78 Million | 112.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 139.42 Million | 1.46 Billion | 1.1 Billion | 370.83 Million | 143.78 Million | 112.55 Million |
| Gross Margin | 0.12 | 0.03 | -0.06 | -1.59 | 0.59 | 0.39 |
| EBIT Margin | -0.89 | -2.03 | -4.51 | -6.74 | -2.70 | -27.58 |
| Profit Margin | -2.77 | -3.77 | -4.83 | -12.57 | -4.15 | -28.98 |
| EBITDA | -16.77 Million | -17.61 Million | -28.05 Million | -21.15 Million | -9.8 Million | -16.37 Million |
| Earnings Before Tax Margin | -0.80 | -2.25 | -4.56 | -6.88 | -2.82 | -27.65 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.11 Million | 18.92 Million | 4.65 Million | 2.97 Million | 8.68 Million | 2.97 Million |
| Cost of Revenue | 6.2 Million | 16.58 Million | 8.76 Million | 7.19 Million | 8.4 Million | 3.47 Million |
| Gross Profit | 1.91 Million | 2.33 Million | -4.1 Million | -4.21 Million | 287 Thousand | -491.51 Thousand |
| Operating Expenses | 2.47 Million | 19.01 Million | 4.1 Million | 4.03 Million | 19.47 Million | 4.05 Million |
| Selling, General and Administrative Expenses | 2.48 Million | - | 4.17 Million | 4.03 Million | - | 4.06 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 10.89 Thousand | -1.45 Million | 69.26 Thousand | - | -459 Thousand | 13.34 Thousand |
| Cost and Expenses | 8.67 Million | 52.73 Million | 12.87 Million | 11.22 Million | 27.88 Million | 7.52 Million |
| Operating Income | -554.83 Thousand | -15.19 Million | -8.21 Million | -8.25 Million | -19.56 Million | -4.54 Million |
| Interest Expense | 2.62 Million | 9.69 Million | 3.32 Million | 303.73 Thousand | 692 Thousand | 7757.89 |
| Income Tax Expense | -4765.46 | -3000.00 | 2664.00 | 1362.78 | 2000.00 | 4.00 |
| Earnings before Tax | -4.95 Million | -35.52 Million | -18.81 Million | -17.5 Million | -32.78 Million | -4.89 Million |
| Net Income | -16.47 Million | -52.44 Million | -18.81 Million | -17.5 Million | -32.78 Million | -4.89 Million |
| Earnings Per Share Basic | -2.39 | - | -5.18 | -6.86 | - | -2.31 |
| Earnings Per Share Diluted | -2.39 | - | -5.18 | -6.86 | - | -2.31 |
| Weighted Average Shares Outstanding | 6.89 Million | 139.42 Million | 3.63 Million | 2.55 Million | 1.46 Billion | 2.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.89 Million | 139.42 Million | 3.63 Million | 2.55 Million | 1.46 Billion | 2.12 Million |
| Gross Margin | 0.24 | 0.12 | -0.88 | -1.42 | 0.03 | -0.17 |
| EBIT Margin | -0.15 | - | -1.59 | -2.36 | - | -1.49 |
| Profit Margin | -2.03 | -2.77 | -4.04 | -5.88 | -3.77 | -1.64 |
| EBITDA | -1.2 Million | - | -7.39 Million | -7.02 Million | - | -4.44 Million |
| Earnings Before Tax Margin | -0.07 | -0.80 | -1.76 | -2.77 | -2.25 | -1.53 |
BREB
CDL
6857
OAMCF
AMNI
VTXPF